Potassium channel antibodies in two patients with reversible limbic encephalitis - Wikidata - awgldk - TriplyDB

Potassium channel antibodies in two patients with reversible limbic encephalitis

Potassium channel antibodies in two patients with reversible limbic encephalitis

http://www.wikidata.org/entity/Q28206692

about

sameAs

The emerging diversity of neuromuscular junction disorders Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms Neuronal central nervous system syndromes probably mediated by autoantibodies Progress in autoimmune epileptic encephalitis Autoimmune encephalitis in psychiatric institutions: current perspectives Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis Disease-relevant autoantibodies in first episode schizophrenia Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens.Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.Emergence of new-onset psychotic disorder following recovery from LGI1 antibody-associated limbic encephalitis.Thyroid antibodies, autoimmunity and cognitive decline: is there a population-based link?Clinical features of limbic encephalitis with LGI1 antibody.Limbic encephalitis: Clinical spectrum and long-term outcome from a developing country perspective.N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.[Antibody-associated diseases of the gray matter of the CNS: diagnosis and treatment].Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies Autoimmune channelopathies: new antibody-mediated disorders of the central nervous system Striatal hypermetabolism in limbic encephalitis.Autoimmune epilepsy: clinical characteristics and response to immunotherapy Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology.An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre.Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis.Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies.Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders.Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia Screening Autoimmune Anti-neuronal Antibodies in Pediatric Patients with Suspected Autoimmune Encephalitis.Autoimmune channelopathies of the nervous system VGKC positive autoimmune encephalopathy mimicking dementia John Newsom-Davis: clinician-scientist and so much more.

P2860

Q24595915-BC2E28E1-5885-4FAC-9D4C-7FE1ECAD06B3 Q24623766-1A3D5D67-84DE-47E9-ADC8-BC7F459485E6 Q24642895-D27A8AA2-BC59-4A15-9CD3-D379EBC131E1 Q26775915-1F28AC65-6440-47BD-AEC4-7338B7052218 Q26824216-1ED4E594-0AEF-47E3-965A-FC2B8BB57204 Q26825224-1188CDD6-4311-4B8D-9AED-B06E223D937C Q27006941-57357837-F6FF-4CCC-AB27-609BCAD3E785 Q28072253-2980E356-95B8-4A84-ABD4-3769CF7FBAC4 Q28077159-588C2078-2FFB-4CC0-8760-AF957BCA7A87 Q28079666-D1CDEC50-6018-4017-9A69-25094BB74915 Q28084055-F6B191A5-ED21-4069-B819-59AD3BB75C32 Q28244864-EDC7281B-D87F-466A-932D-129E5B9554D9 Q28296584-46072CFB-7C0F-4D30-A89B-5D0ADBA41C05 Q28298099-28DA2FD5-8472-4927-9926-B8F92F78A491 Q30276550-39A069C4-C8D4-41BD-A740-1289E560867B Q30578301-118DFFFA-B1DB-4809-8BE9-2370FED8DE3F Q33375581-0F47BF76-3798-4FA5-A870-C86D27CD1C76 Q33552867-2A44D917-4667-4383-ABA0-1BBB8CCCC403 Q33795238-7DCF0723-D789-4A59-A122-297AE28B7EA9 Q33825874-AAE84FD7-AC5C-4D14-A68C-2DFB24E3A04C Q33877813-479F9804-6DE9-405D-98C5-650825370D2F Q33882739-D67F0D9D-90E1-4B23-A93B-63B8EF8F90B0 Q33966060-FBAB7B42-F886-4905-B94A-89A8AA0D9439 Q34007635-8F777DBA-386C-4EFC-AD3E-F9E7A5135BB7 Q34122865-E849D953-38FB-465C-B9F6-C9179D79AC6A Q34127075-0CC3063E-C3AD-4B61-A9FA-A75314A77080 Q34167246-82DA3231-73AE-4D5D-AA77-0698E132A440 Q34232346-B6F002B4-C9D2-4B63-BD21-1F60655F96E9 Q34263857-A0EEB2CD-9A0A-450C-B118-026160297DCD Q34350247-A095D190-F1AC-402A-AF7A-9F407CFC5C6C Q34409973-75B8E45D-0162-444D-84A4-2078CBDCE738 Q34449781-0243BEED-A2F2-4B3B-BC2C-47581A44614E Q34490340-1068FF36-F32C-42C4-A9B2-A6752E6B9F72 Q34581010-F1A5C2E6-65CA-42C6-9F55-E86DF300CECB Q34582727-D06EEDCF-23AF-4FA3-BBA2-C8711D065776 Q34686855-AB96C827-6055-4182-9AA1-4E8F7B4B0BA5 Q34965352-E669DD76-E47D-4852-B35A-CBE698C695C5 Q35151881-FF850C7E-2E3D-45D5-9158-6BBCA9870FFE Q35588646-435CC0FA-830E-49C2-95D6-6C43035D109D Q35606729-1CC45E4D-17EC-4D10-94F1-707EA4C2739E

P2860

Potassium channel antibodies in two patients with reversible limbic encephalitis

http://www.wikidata.org/entity/Q28206692

description

2001 nî lūn-bûn

@nan

2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Potassium channel antibodies in two patients with reversible limbic encephalitis

@ast

Potassium channel antibodies in two patients with reversible limbic encephalitis

@en

Potassium channel antibodies in two patients with reversible limbic encephalitis

@nl

type

label

Potassium channel antibodies in two patients with reversible limbic encephalitis

@ast

Potassium channel antibodies in two patients with reversible limbic encephalitis

@en

Potassium channel antibodies in two patients with reversible limbic encephalitis

@nl

prefLabel

Potassium channel antibodies in two patients with reversible limbic encephalitis

@ast

Potassium channel antibodies in two patients with reversible limbic encephalitis

@en

Potassium channel antibodies in two patients with reversible limbic encephalitis

@nl

P1433

Q28206692-7CCB5E7C-D605-4C4D-8816-C4024E8C3F7B

P1476

Q28206692-0A64B8FD-2039-4DF5-9132-A8E5FCC6E82E

P2093

Q28206692-1269DC49-D88F-42D7-8032-5BFD4DB72358

Q28206692-3AB83D08-4B80-462A-9006-2B76831DFA83

Q28206692-8C745161-0A3E-4F85-A2F8-3819419EF5E6

Q28206692-A0BBAB80-0CA9-4CBF-BCF0-1C5D261E2D7F

Q28206692-A40D44C0-1919-4DF7-8448-47959D28D68B

Q28206692-D77217B2-D8A0-4CAE-9506-E938CC56E683

Q28206692-F76F23D6-300F-4FD3-8953-4A0B03EC7DF3

P2860

Q28206692-0CDEE06E-4C75-409F-B82E-C083AC043ED7

Q28206692-4639178D-D7E7-4D16-9F22-4C999AD43A72

Q28206692-4FE99231-ED94-4E8F-91C0-0DAEF019306E

Q28206692-517CCCCF-36AB-4101-84A4-AFC4269E69DC

Q28206692-751B78C2-CAEF-4FDE-98AE-A8F19F6C0434

Q28206692-75D655FC-DA15-4A36-BF5D-F36D67192037

Q28206692-79E68145-D763-47CB-881C-E3E582DEC4E6

Q28206692-7CE3629C-060D-4C86-9283-3D86F1FE160D

Q28206692-815656EA-A2BC-4293-8231-616153CDEF17

Q28206692-85EFDD38-C5D6-450E-AB7A-FB778D5D57EE

P304

Q28206692-5A13B385-AB63-4F4C-8A45-89A0CF08F1B6

P31

Q28206692-F2363A02-E7E7-4A6F-B63E-F2611E7466AD

P3181

Q28206692-7C551211-96D9-4D4D-8A7E-321FBE829E7A

P356

Q28206692-43DD2EAA-BA78-439E-9F84-3AA1EB51ABE2

P407

Q28206692-224496AE-3F98-481F-8176-D8C85EEF26C6

P433

Q28206692-A691B54A-6EE7-4C78-9764-4894BE4F1336

P478

Q28206692-70EE0BF6-2667-40C4-8A92-D6111ABAF0BD

P577

Q28206692-1E5428BD-DC0D-4596-83BE-D47BA8E10091

P698

Q28206692-F8D54A81-9F05-480A-B302-045BEE932211

P921

Q28206692-39149A9A-FF34-46A2-83C2-573ED08C5266

Q28206692-3B961783-B2EF-403A-A6CF-8460A06AE619

P3181

P356

P1433

Annals of Neurology

P1476

Potassium channel antibodies in two patients with reversible limbic encephalitis

@en

P2093

A Vincent

http://www.w3.org/2001/XMLSchema#string

C Buckley

http://www.w3.org/2001/XMLSchema#string

E Tüzün

http://www.w3.org/2001/XMLSchema#string

J Oger

http://www.w3.org/2001/XMLSchema#string

K Carpenter

http://www.w3.org/2001/XMLSchema#string

L Clover

http://www.w3.org/2001/XMLSchema#string

M Jackson

http://www.w3.org/2001/XMLSchema#string

P2860

A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer

"Limbic encephalitis" and its association with carcinoma

A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy

Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.

Morvan's syndrome associated with voltage-gated K+ channel antibodies.

Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody.

Morvan's fibrillary chorea: remission after plasmapheresis.

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia.

Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy.

Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma.

P304

73-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1545677

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ANA.1097

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2001-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11456313

http://www.w3.org/2001/XMLSchema#string

P921